Diabetes, cardiovascular disease and the microcirculation

Area of Science:

• Endocrinology
• Cardiology
• Vascular Biology

Background:

• Cardiovascular disease (CVD) is the primary cause of death in type 2 diabetes mellitus (T2DM).
• Hypertension prevalence and impact are significantly higher in T2DM patients than in the general population.
• Conventional risk factors do not fully explain the elevated CVD burden in T2DM.

Purpose of the Study:

• To review vascular tree alterations in T2DM compared to the general population.
• To examine the effects of anti-diabetes drugs on microvascular outcomes.
• To explore potential shared etiological mechanisms for CVD and hypertension in T2DM.

Main Methods:

• Literature review of studies on vascular changes in T2DM.
• Analysis of clinical trial data on anti-diabetic drug effects on microvasculature.
• Synthesis of hypotheses regarding common causalities of CVD and hypertension in T2DM.

Main Results:

• T2DM is associated with distinct vascular changes not fully explained by traditional risk factors.
• The heightened impact of hypertension in T2DM suggests increased vascular sensitivity or shared pathways.
• Established anti-diabetic medications show variable effects on microvascular complications.

Conclusions:

• Understanding the unique vascular pathophysiology in T2DM is crucial for managing CVD risk.
• Further research into shared etiological mechanisms is needed to develop targeted therapies.
• Integrated management of T2DM, hypertension, and vascular health is essential.